Prestige Consumer Healthcare In — Earnings Quality Grade F
PBH · Healthcare
Major red flags
Screening Summary
Management Signals
Financial Trends
Revenue & Net Income ($B)
Margins (%)
18-Point Screening
Revenue Quality
DSO 65 days, change +5 days YoY
AR outpaced revenue for 2 consecutive years
Revenue 1.1%, CFFO 1.0%. Cash follows revenue
Expense Quality
Inventory 6.5% vs COGS 0.5%. Normal
CapEx growth -13.9% vs revenue 1.1%. Normal
SG&A/Gross Profit = 41.6%. Normal
Gross margin 55.8%, change +0.3pp. Stable
Cash Flow Quality
CFFO/NI = 1.17. Profits backed by cash
FCF $0.2B, FCF/NI = 1.13
Accruals ratio = -1.1%. Low accruals
Cash $0.1B covers only 9% of debt $1.0B
Balance Sheet Health
Goodwill+Intangibles $2.8B = 154% of equity. Over 50%
Debt/EBITDA = 2.9x. Healthy
Other assets -42.8% vs revenue 1.1%. Normal
No write-off data
Acquisition Risk
FCF after acquisitions positive
Goodwill+Intangibles change -1% YoY. Normal
Manipulation Score
M-Score = -2.38 (< -2.22). Unlikely manipulator
Portfolio monitoring
Monitor PBH continuously
The full checks and model details are free to read. Use Watchlist to track your holdings; Pro adds automatic quarterly rescoring, risk-event email alerts, scans up to 50 tickers, and export workflows.
Beneish M-Score
Altman Z-Score
Generated from public financial data using forensic accounting frameworks. Not investment advice. Data: Yahoo Finance · 2026-04-25